Rua Bioscience Limited logo

Rua Notice of 2024 Annual Shareholders' Meeting

AGM16 October 2024RUAHealthcare

MEETING ANNOUNCEMENT


NZX:RUA


Thursday 17 October 2024


Rua Bioscience Limited 2024 Annual Shareholders Meeting


The 2024 Annual Meeting of Rua Bioscience Limited (Rua) will be held virtually via

Computershare’s online meeting platform at https://meetnow.global/nz at 10.00am (New Zealand

time) on Monday, 4 November 2024.


Attached is the Notice of Meeting, which includes details for proxy voting, the online meeting

details and the resolutions for shareholder consideration.



ENDS


For more information, please visit www.ruabio.com or contact:

Paul Naske

Chief Executive Officer

+64 (21) 445 154

www.ruabio.com





























PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com

---


 

 

 

 

 

 

 

 

 

 

 

Notice of 2024 Annual Shareholder Meeting  

 

 

 

  

 
 


Notice of Annual Meeting of Shareholders 

 

17

th

 October 2024 

 

Dear Shareholder, 

 

The 2024 Annual Meeting of Rua Bioscience Limited (Rua) will be held virtually via Computershare’s 

online meeting platform at https://meetnow.global/nz at 10.00am (New Zealand time) on Monday, 4 

November 2024. 

We have decided to again hold a virtual‐only meeting this year as that format is logistically more 

straightforward and less expensive.  In addition, following the meeting we will be conducting a 

community engagement day on November 5

th

 at our facility at Ruatorea where so many of our 

shareholders reside.  This will provide investors with the opportunity to meet and interact with 

members of the Board and Management.  For further details about the meeting please go to 

www.ruabio.com or our social media channels.  

When participating online, shareholders will require their shareholder number, found on the enclosed 

proxy form for verification purposes.  Details on how to participate online are set out below under the 

heading “Online Participation Details”. 

Items of Business 

1. Company Overview  

2. Chair’s Address 

3. Chief Executive’s Presentation 

4. Annual Results Presentation

 

5. Shareholder Questions 

5.1. To consider any shareholder questions submitted to the Annual Meeting (to the extent these 

questions have not already been addressed in the Chair’s Address, the Chief Executive 

Officer’s Presentation or the Annual Results Presentation).   

For further details, see Explanatory Note 1. 

6. Ordinary Resolution 1 –

 Auditors Remuneration 

6.1. To consider and, if thought fit, pass the following Ordinary Resolution, requiring approval by 

a simple majority of the votes of shareholders entitled to vote and voting: 

6.1.1. That the Board be authorised to fix the auditor’s remuneration. 

For further details, see Explanatory Note 2. 

 
 


7. Ordinary Resolution 2 – Approval of Issue of New Ordinary Shares 

7.1. To consider and, if thought fit, pass the following Ordinary Resolution, requiring approval by 

a simple majority of the votes of shareholders entitled to vote and voting: 

7.1.1. That the Directors are authorised to issue up to 37,311,522

 new ordinary fully paid 

shares in the Company (New Shares) on the following terms: 

(a) The New Shares may be issued to any person subject to the Company 

complying with the requirements of the Financial Markets Conduct Act 2013 

and the NZX Listing Rules in relation to any such 

issue. 

(b) The New Shares may be issued through a single placement of up to  

37,311,522 New Shares or via separate placements of up to 37,311,522 New 

Shares in aggregate. 

(c) Each New Share shall be issued at an issue price of not less than $0.03. 

(d) The New Shares may

 be issued at any time during the course of the 12 month 

period following the passing of this resolution. 

(e) The New Shares, when issued, shall rank pari passu (equally) with all existing 

ordinary shares in the Company. 

For further details, see Explanatory Note 3. 

8. General Business 

8.1. To 

consider any other business that can be properly brought before the meeting. 

Further Information and Explanatory Notes 

Further information relating to the resolutions is set out in the Explanatory Notes accompanying this 

Notice of Meeting.  Please read and consider the resolutions together with the Explanatory Notes.  

Online Participation Details 

All shareholders

 will have the opportunity to attend the Annual Meeting online through the 

Computershare Meeting Platform using a computer, laptop, tablet or smartphone – simply visit 

https://meetnow.global/nz and follow the prompts under the ‘Rua Bioscience Limited Annual 

Meeting’ icon.  

Your browser will need to be compatible with the latest version of Chrome, Safari or Edge. If you are 

a shareholder, you will also need your CSN/Securityholder Number, which can be found on your proxy 

form or email invitation (where applicable).  

Shareholders will be able to view the 

presentations on their selected devices. Audio will stream 

through your selected device, so please ensure that the volume control on your headphones or device 

is turned up. Instructions on how to participate ‘virtually’ are provided in the Virtual Meeting Guide 

available at www.computershare.com/vm‐guide‐nz.  

Shareholders will be able to vote

 on the resolutions to be put to shareholders and will have the ability 

to ask questions on their selected devices. Shareholders will still be able to appoint a proxy to vote for 

them, as they otherwise would, by following the instructions on the proxy form and in this Notice of 

Annual Meeting. If you have any questions on, or need assistance with, the online process, please 


contact Computershare on +64 9 488 8777 between 8.30am and 5.00pm (New Zealand time) Monday 

to Friday 

Attendance and Voting 

Your rights to vote may be exercised by:  

(a)Voting at the virtual meeting and casting your vote via the Computershare Online Meeting

Platform at https://meetnow.global/nz during the meeting.  Instructions for how to do this is

included in the Virtual Meeting Guide; or

(b)Appointing a proxy (or representative) to attend and vote in your place.  The proxy need not

be  a  shareholder  of  Rua  and  the  form  of  appointment  of  a  proxy  and  voting  instructions

accompany this Notice of Meeting.  You can appoint a proxy online or complete and send the

Proxy  Voting  Form  (enclosed  with  this  Notice  of  Meeting)  by  post,  email  (as  a  scanned

attachment) so that it is received by Computershare by no later than 10.00am on Saturday 2

November 2024.

I look forward to seeing you at the Annual Meeting and thank you for your ongoing support.  

By order of the Board.  

Anna Stove 

Chair 

17

th 

October 2024

 
 


Explanatory Notes 

Note 1 – Shareholder Questions 

Shareholders may submit written questions to be considered at the Annual Meeting.  Written 

questions should be sent by email to paul.naske@ruabio.com with the reference to “Annual Meeting” 

in the subject line or by post to “Annual Meeting”, Rua Bioscience Limited, 1 Commerce Place, 

Awapuni, Gisborne 4071.

  Rua reserves the right not to address any questions that, in the Board’s 

opinion, are not reasonable to address in the context of an annual meeting.  

Note 2‐ Auditor’s Remuneration  

Ordinary Resolution 1  

PricewaterhouseCoopers is automatically reappointed as auditor under section 207T of the 

Companies Act 1993.  Under section 207S 

of the Companies Act 1993, the auditor’s fees and expenses 

must be fixed in the manner that is determined at the annual meeting of the Company.  This resolution 

therefore authorises the Board to fix the fees and expenses of PricewaterhouseCoopers as the 

Company’s auditor for the current financial year.  

Note 3

 – Approval of issue of new ordinary shares 

Ordinary Resolution 2 

The Directors wish to seek the approval of shareholders to enable them to issue up to a further 

37,311,522 new fully paid ordinary shares in the Company (New Shares) to assist with ongoing funding 

requirements of the Company, 

including scaling its sales efforts in key international markets, 

particularly Germany, Australia and UK.  The New Shares will be the same class of shares as the existing 

ordinary shares on issue in the Company. 

The Company’s 2024 Annual Report (Annual Report) stated:  

“Given the Group’s net operating loss of $13,718,754

 and net operating cash outflow of $3,736,479 

for the year ended 30 June 2024, in addition to its reduced liquid net asset position, the Board and 

management have prepared cash flow forecasts for the next 12 months.  These indicated that the 

Group will not have sufficient cash to meet its 

minimum expenditure commitments and support its 

current levels of activity without undertaking additional action.” 

In addition to a property sale referred to in the Annual Report (see note 2.(f)(i)), Ordinary Resolution 

2 forms part of the Company’s actions to ensure it meets its going concern assumption.  

Each New Share would have

 an issue price of not less than $0.03.  An issue price of $0.03 represents 

a 36% discount to the Volume Weighted Average Price (VWAP) of the Company’s shares traded on 

the NZX during the 20 trading days up to the 15th October 2024.  The expectation would be that the 

Board would seek to issue the New Shares at a share price that is no more than a 36% discount to the 

prevailing current market price for the Company’s shares at the time of issue of the New Shares.  

The New Shares would be required to be issued within 12 months

 from the date that shareholders 

resolve to approve the issue of the New Shares.  If any New Shares are not issued within this 

timeframe, the approval to issue those New Shares would lapse. 

The purpose of seeking approval to potentially issue the New Shares would be to provide the Board 

with maximum flexibility to raise capital to assist with ongoing funding requirements of the Company, 

including executing its growth plans in key international markets. 

 
 


 

Any placement of the New Shares will occur as part of the Company’s broader capital raising 

endeavours, which will likely involve an offer of shares to the Company’s existing shareholders, either 

through a pro rata entitlement offer or a share purchase plan, at a price no higher than the issue 

price 

for New Shares under the placement. 

As at the date of this notice, the Company does not have an indication of the party or parties to whom 

the New Shares may be issued pursuant to the proposed further placement capacity, nor does it have 

any specific transactions in mind for

 the utilisation of the proposed further placement capacity. 

The New Shares would represent 22.79% of the total number of shares on issue in the Company as at 

the date of this notice (being 163,718,833 ordinary shares).  If all of the New Shares were issued, then 

based on the total number 

of shares on issue in the Company as at the date of this notice, the total 

number of shares on issue would increase to 201,030,355. 

A worked example showing the dilutionary impact of the issue of the New Shares is as follows: 

 Example shareholder percentage currently:  5.00% 

 Example shareholder

 percentage if all New Shares are issued:  4.07% 

Note that the above does not take into account any additional dilution which may occur if the 

Company was to issue further new shares, either before or after the date of the Annual Meeting, in 

accordance with other provisions of the NZX 

Listing Rules, including under Listing Rule 4.3 (which 

permits certain pro rata issues and issues under share purchase plans without shareholder approval) 

or under Listing Rule 4.5.1 (which permits the issue of ordinary shares representing up to 15% of the 

total number of shares on issue in any 12 month period

 without shareholder approval).  The Company 

currently has capacity to issue up to a further 12.21% of equity securities under Listing Rule 4.5.1, 

based on the total number of its shares on issue as at the date of this notice.  The Board does not 

consider that this current placement capacity will 

give the Company flexibility to raise a sufficient level 

of capital (in addition to the capital it can raise in accordance with Listing Rule 4.3) to execute its 

growth plans. 

Requirement for Resolution 

Listing Rule 4.1.1 requires that the issue of the New Shares be approved by an ordinary resolution of

 

the existing shareholders of the Company in accordance with Listing Rule 4.2.1. 

Each of the Directors of the Company and their Associated Persons (as defined in the Listing Rules) are 

prohibited from voting on this resolution in accordance with Listing Rule 6.3.1, other than where the 

vote is cast by 

a Director or Associated Person as a proxy or voting representative for a person who is 

entitled to vote, and in accordance with the express directions given by that person in the Proxy Voting 

Form to vote for or against the resolution. 

Consequences if resolution is not approved 

If the resolution

 to approve the issue of the New Shares is not approved, the Company will seek 

alternative funding to assist with financing growth opportunities, and may seek further shareholder 

approval in the future by way of a vote at a special meeting or future annual meeting. 

Voting by Proxy 

Any shareholder 

who is entitled to vote at the Annual Meeting may appoint a proxy to attend and 

vote on their behalf.  A shareholder wishing to appoint a proxy should complete and return the Proxy 

Voting Form (enclosed with this Notice of Meeting) in the manner specified on the Proxy Voting Form 


so that the form is received by Computershare no later than 48 hours before the time for holding the 

Annual Meeting (i.e., before 10:00am on 2 November 2024).  A proxy need not be a shareholder of 

Rua.  The Chair of the meeting is willing to act as proxy for any shareholder who may wish to appoint 

her for that  purpose.  The Chair will vote as directed on any resolutions, and intends to  vote any 

discretionary  proxies  in  accordance  with  the  Board  recommendations,  being  in  favour  of  all 

resolutions (to the extent permitted by the NZX Listing Rules and Rua’s constitution).  The 

Chair is 

prohibited  from  voting  any  discretionary  proxy  in  respect  of  Ordinary  Resolution  2  (including  any 

motions from the floor and/or any resolutions put before the meeting to amend Ordinary Resolution 

2) in accordance with Listing Rule 6.3.1 and any such discretionary proxy will not be valid.

To direct your proxy

 how to vote on the resolutions, you should tick the appropriate box on the Proxy 

Voting Form.   If you appoint a proxy but do not tick one of the boxes in relation to a resolution, you 

will be deemed to have granted your proxy the discretion to cast your votes as he or she decides. In 

so doing you acknowledge that the proxy may exercise your right to vote even if he or she has an 

interest in the outcome of the resolutions (provided that he or she is not disqualified from voting 

under the NZX Listing Rules).  

If, in appointing

 a proxy, you have inadvertently not named someone to be your proxy, or your named 

proxy  does  not  attend  the  meeting,  the  Chair  of  the  meeting  will  be  your  proxy  and  will  vote  in 

accordance with your express direction.   

If you do not attend the Annual Meeting or appoint a 

proxy, then no vote will be exercised in respect 

of your shareholding.  

Entitlement to Vote 

All persons on Rua’s register of shareholders as the holders of shares at 5:00pm on 1 November 

2024 will be entitled to vote on the resolutions at this Annual Meeting.  

If you have appointed a

 proxy to attend the Annual Meeting in your place, you may still observe the 

Annual Meeting (but only your proxy may cast your votes).  

Any corporation that is a shareholder may appoint a person as its representative to attend the Annual 

Meeting and vote on its behalf, in the same manner as that in which it could appoint a proxy.  A 

corporation wishing to appoint a person must ensure that the representative brings an original of the 

notice appointing him or her to the meeting.  To assist with administration of the Annual Meeting, Rua 

would  be  grateful  if  notices  appointing  representatives

  are  delivered  to  Computershare  Investor 

Services Limited at Private Bag 92119, Auckland 1142 or at corporateactions@computershare.co.nz, 

at  least  48  hours  before  the  time  for  the  holding  of  the  Annual  Meeting  (i.e.,  before  10:00am  on 

Saturday 2 November 2024).   

Voting on all of the resolutions is to be by way of 

poll.  No persons are restricted from voting on, or 

acting as a discretionary proxy in relation to, any of the resolutions referred to in this notice of Annual 

Meeting, subject to the voting restrictions noted above in respect of Ordinary Resolution 2.  

Results 

Following the Annual Meeting, the results will be

 posted at www.ruabio.com and on www.nzx.com.

---

Your secure access information
Control Number: CSN/Shareholder Number:

PLEASE NOTE: You will need your CSN/Shareholder Number and postcode or country of residence (if outside New Zealand)

to securely access InvestorVote and then follow the prompts to appoint your proxy and exercise your vote online.

Turn over to complete the form to vote

Proxy/Voting Form

How to Vote on Items of Business

All your securities will be voted in accordance with your directions.

Appointment of Proxy

All shareholders of the Company entitled to attend and vote at the virtual meeting

are entitled to appoint a proxy to attend and vote for them instead. A proxy need

not be a shareholder of Rua. The Chair of the meeting is willing to act as proxy for

any shareholder who may wish to appoint them for that purpose. The Chair will

vote as directed on any resolutions, and intends to vote any discretionary proxies

in accordance with the Board recommendations, being in favour of all resolutions

(to the extent permitted by the NZX Listing Rules and Rua’s constitution).

Voting on your holding

To direct your proxy how to vote on the resolutions, you should tick the

appropriate box on the Proxy Voting Form. If you appoint a proxy but do not tick

one of the boxes in relation to a resolution, you will be deemed to have granted

your proxy the discretion to cast your votes as he or she decides. In so doing you

acknowledge that the proxy may exercise your right to vote even if he or she

has an interest in the outcome of the resolutions (provided that interest does not

disqualify him or her from voting under the NZX Listing Rules).

A proxy is able to vote on motions from the floor and/or any resolutions put

before the meeting to amend the resolutions stated in this form unless he or she

is disqualified from voting under the NZX Listing Rules.

If, in appointing a proxy, you have inadvertently not named someone to be your

proxy, or your named proxy does not attend the meeting, the Chair of the meeting

will be your proxy and will vote in accordance with your express direction.

Voting Restrictions

Each of the Directors of the Company and their Associated Persons (as defined in

the Listing Rules) are prohibited from voting on resolution 2 in accordance with

Listing Rule 6.3.1, other than where the vote is cast by a Director or Associated

Person as a proxy or voting representative for a person who is entitled to vote,

and in accordance with the express directions given by that person in the Proxy

Voting Form to vote for or against the resolution.

Attending the Virtual Meeting

All shareholders will have the option to attend, vote and participate in the Annual

Shareholder Meeting online via an internet connection using a laptop, tablet or

smartphone. For further details see the Virtual Meeting Guide that accompanies

this form. If a representative of a corporate security holder or proxy is to attend

the virtual Meeting, they may need to provide evidence of your authorisation to

act prior to admission.

If a shareholder has appointed a proxy, they may attend the virtual meeting but

will not be able to vote.

Signing Instructions for Postal Forms

Individual

Where the holding is in one name, the shareholder must sign.

Joint Holding

Where the holding is in more than one name, all of the shareholders

should sign.

Power of Attorney

If this Proxy Form has been signed under a power of attorney, a copy of the

power of attorney (unless already deposited with the Company) and a signed

certificate of non-revocation of the power of attorney must be produced to the

Company with this Proxy Form.

Companies

This form should be signed by a Director jointly with another Director, or a

Sole Director can also sign alone. Please sign in the appropriate place and

indicate the office held.

Comments & Questions

If you have any comments or questions for the company, please write them

on a separate sheet of paper and return with this form.

Lodge your Proxy

Online

www.investorvote.co.nz

By Mail

Computershare Investor Services Limited

Private Bag 92119, Auckland 1142, New Zealand

By Email

corporateactions@computershare.co.nz

For all enquiries contact

+64 9 488 8777

corporateactions@computershare.co.nz

Lodge your proxy online, 24 hours a day, 7 days a week:

www.investorvote.co.nz

Scan the QR code to vote now.

Smartphone?

For your proxy to be effective it must be received by 10.00am on Saturday, 2nd November 2024.

The 2024 Annual Meeting of Rua Bioscience Limited will be held at 10.00am (New Zealand time)

on Monday, 4th November 2024 online via Computershare Investor Services Limited’s meeting

platform https://meetnow.global/nz.

Proxy/Voting Form
Appoint a Proxy to Vote on Your Behalf

STEP 1

hereby appointof

or failing him/herof

as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions at the Annual General Meeting of

Rua Bioscience Ltd to be held virtually through the Computershare online meeting platform https://meetnow.global/nz on Monday, 4th November 2024 at

10.00am and at any adjournment of that meeting.

I/We being a shareholder/s of Rua Bioscience Ltd

Items of Business - Voting Instructions/Ballot Paper

STEP 2

Please note: In the event I/we have not expressed any intention or the intention is unclear (in my/our proxy’s sole opinion),my/our proxy will vote as

they see fit.

Signature of Shareholder(s) This section must be completed.

SIGN

or Sole Director/Director

Shareholder 1Shareholder 2Shareholder 3

Contact Name Contact Daytime Telephone Date

Ordinary Resolutions

1.

That the Board be authorised to fix the auditor’s remuneration.

2.

That the Directors are authorised to issue up to 37,311,522 new ordinary fully paid shares in the

Company (New Shares) on the following terms:

(a) The New Shares may be issued to any person subject to the Company complying with the

requirements of the Financial Markets Conduct Act 2013 and the NZX Listing Rules in relation to

any such issue.

(b) The New Shares may be issued through a single placement of up to 37,311,522 New Shares or via

separate placements of up to 37,311,522 New Shares in aggregate.

(c) Each New Share shall be issued at an issue price of not less than $0.03.

(d) The New Shares may be issued at any time during the course of the 12 month period following the

passing of this resolution.

(e) The New Shares, when issued, shall rank pari passu (equally) with all existing ordinary shares in

the Company.

For

Against

Abstain

Proxy

Discretion

or Director (if more than one)

If your proxy is not the Chairman of the Meeting or any other director of the Company, please ensure that you provide their contact details (phone

and email address). If this information is not provided, we cannot guarantee remote admission to the virtual meeting for your proxy.

Proxy contact Details (Phone): and (Email):

---

Attending the meeting online
Our online meeting provides you the opportunity to

participate online using your smartphone, tablet or computer.

If you choose to attend online you will be able to view a live

webcast of the meeting, ask questions and submit your

votes in real time.

You

will need the latest version of Chrome, Safari or

Edge. Please ensure your browser is compatible.

HOW TO PARTICIPATE IN VIRTUAL/HYBRID MEETINGS

Visit https://meetnow.global/nz

When successfully authenticated, the home screen

will be displayed. You can watch the webcast, vote,

ask questions, and view meeting materials in the

documents folder. The image highlighted blue

indicates the page you have active.

The webcast will appear and begin automatically

once the meeting has started.

Voting

Resolutions will be put forward once voting is

declared open by the Chair. Once the voting has

opened, the resolution and voting options will appear.

To vote, simply select your voting direction from the

options shown on screen. You can vote for all

resolutions at once or by each resolution.

Your vote has been cast when the green tick appears.

To change your vote, select ‘Change Your Vote’.

Q&A

Any eligible shareholder/proxy attending the meeting

r

emotely is eligible to ask a question.

S

elect the Q&A tab and type your question into the

box at the bottom of the screen and press 'Send'.

Navigation

Access

Access the online meeting at

https://meetnow.global/nz, and select the required

meeting. Click 'JOIN MEETING NOW'.

If you are a shareholder:

Select 'Shareholder' on the login screen and enter

your CSN/Holder Number and Post Code. If you are

outside New Zealand, simply select your country

from the drop down box instead of the post code.

Accept the Terms and Conditions and click Continue.

If you are a guest:

Select Guest on the login screen. As a guest, you will

be prompted to complete all the relevant fields

including title, first name, last name and email

address.

Please note, guests will not be able to ask questions

or vote at the meeting.

If you are a proxy holder:

You will receive an email invitation the day before the

meeting to access the online meeting. Click on the

link in the invitation to access the meeting.

Contact

If you have any issues accessing the website please

c

all +64 9 488 8700.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.